Alpha olefin biosynthesis via whole cell biocatalysis
A novel biocatalytic process using lipases and metal-dependent enzymes for converting fatty acid methyl esters into alpha olefins. This one-pot method offers high efficiency and potential for industrial-scale production.
Overview
This biocatalytic approach utilizes lipases and metal-dependent enzymes to convert fatty acid methyl esters into linear alpha olefins. The process leverages the catalytic capabilities of nonheme-diiron enzymes, such as UndB, to drive biotransformation with high efficacy. Alpha olefins are valuable chemical building blocks used in the production of detergents, lubricants, and synthetic fibers.
Technical specifications
Key features:
- Enzyme combination: Lipases convert fatty acid methyl esters or triglycerides to fatty acids, while nonheme-diiron enzymes, specifically UndB, transform these into alpha olefins.
- One-pot synthesis: Integrated use of these enzymes enables a streamlined process, reducing the need for multiple reaction steps and minimizing waste.
- High efficiency: The biocatalytic system is designed to operate with high substrate concentrations, aiming for near-complete conversion and high productivity.
Technology readiness level
This technology is currently at TRL 4, having been validated in a laboratory environment. Efforts are ongoing to optimize microbial strains for industrial-scale application, with future plans for process development and scale-up.
About UC Berkeley
UC Berkeley is a comprehensive public research university of global scale, known for cross‑disciplinary inquiry and a high‑intensity research culture. Industry engages on campus through shared user facilities, project‑based collaborations, and embedded innovation spaces, with proximity to a U.S. Department of Energy national laboratory enabling joint programs and access to specialized instrumentation. Its Bay Area location connects partners to deep talent pipelines and a dense startup ecosystem, enabling rapid prototyping and iteration alongside regional suppliers and investors. Research is supported by competitive federal funding from agencies such as the National Science Foundation, Department of Energy, National Institutes of Health, and DARPA. A dedicated technology transfer office streamlines IP, sponsored research, material transfer agreements, and startup formation, complemented by accelerators and proof‑of‑concept resources.
delivered to your inbox.